Últimos Artículos de Diabetes, Obesity and Metabolism
- Chronic kidney disease in type 2 diabetes: The size of the problem, addressing residual renal risk and what we have learned from the CREDENCE trial
- Glucagon‐like peptide‐1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity—a systematic review and network meta‐analysis
- Research advances in understanding crosstalk between organs and pancreatic β‐cell dysfunction
- Medication adherence to sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists: A meta‐analysis
- Topical menthol, a pharmacological cold mimic, induces cold sensitivity, adaptive thermogenesis and brown adipose tissue activation in mice
- Time trends in hypertension and diabetes prevalence by body mass index categories in Brazilian adults from 2006 to 2023
- Effectiveness of switching from dipeptidyl peptidase‐4 inhibitor to oral glucagon‐like peptide‐1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching
- Individual treatment effects of sodium‐glucose co‐transporter‐2 inhibitors on the risk of chronic kidney disease in patients with type 2 diabetes: A counterfactual prediction model based on real‐world data
- An overview of the CANVAS Program and CREDENCE trial: The primary outcomes and key clinical implications for those managing patients with type 2 diabetes
- Incidence and progression of diabetic retinopathy in patients treated with glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter 2 inhibitors: A population‐based cohort study
- Issue Information
- Metformin beyond type 2 diabetes: Emerging and potential new indications
- Clinical efficacy and cost‐effectiveness of metformin in different patient populations: A narrative review of real‐world evidence
- Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes
- Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
- Metformin: Therapeutic profile in the treatment of type 2 diabetes
- Regional disparities in type 2 diabetes prevalence and associated risk factors in the United States
- The causal relationship between plasma protein‐to‐protein ratios and type 2 diabetes and its complications: Proteomics mendelian randomization study
- Clinical factors influencing the success rate of radioiodine treatment for Graves' disease
- Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study